Still no submission to the FDA for the PCH removal.
Disappointing. Let's hope the share price doesn't cop a battering.
- Forums
- ASX - By Stock
- ATH
- Ann: Appendix 4D Half Yearly Report and Accounts
ATH
alterity therapeutics limited
Add to My Watchlist
0.00%
!
1.6¢

Ann: Appendix 4D Half Yearly Report and Accounts, page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $147.3M |
Open | High | Low | Value | Volume |
1.7¢ | 1.8¢ | 1.5¢ | $747.2K | 46.34M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
21 | 9831152 | 1.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.6¢ | 5520481 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
21 | 9831152 | 0.015 |
14 | 7337587 | 0.014 |
24 | 12360524 | 0.013 |
31 | 12023463 | 0.012 |
26 | 19412532 | 0.011 |
Price($) | Vol. | No. |
---|---|---|
0.016 | 5520481 | 13 |
0.017 | 7327884 | 13 |
0.018 | 16334683 | 26 |
0.019 | 21615710 | 16 |
0.020 | 6190698 | 18 |
Last trade - 13.26pm 28/07/2025 (20 minute delay) ? |
Featured News
ATH (ASX) Chart |
The Watchlist
P.HOTC
HotCopper
Frazer Bourchier, Director, President and CEO
Frazer Bourchier
Director, President and CEO
SPONSORED BY The Market Online